Aranorosin (1) is a novel antifungal antibiotic isolated from the fungal strain Pseudoarachniotus roseus (HIL parable to ketoconazole in the in vitro assays. Also isolated from the same species were aranorosinol A (2) and aranorosinol B (3)4), which were the reduced forms of 1 at C8-position and aranochlor A (4) and aranochior B (5)5), which were the monoepoxy chloro compounds.
The antifungal activity was found to be reduced conhexanone bisoxirane moiety may have a critical role for the antifungal activity of aranorosin (1) . This prompted us to initiate a semisynthetic program to study the structure-activity relationships and to prepare more Table 1 . The compounds were characterized by DCI-MS and 1H NMR (90 and 300MHz) spectra recorded in CDCl3.
It was evident from the data that the antifungal activity reduced gradually with increasing lipophilicity (increasing the chain length of the esters and ethers) group is necessary for the antifungal activity. All the modifications so far indicate that the cyclohexanone bisoxirane moiety is essential for the antifungal activity of aranorosin (1) . The influence of side chain on the activity profile could not be evaluated .
